JP2012505178A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505178A5
JP2012505178A5 JP2011530475A JP2011530475A JP2012505178A5 JP 2012505178 A5 JP2012505178 A5 JP 2012505178A5 JP 2011530475 A JP2011530475 A JP 2011530475A JP 2011530475 A JP2011530475 A JP 2011530475A JP 2012505178 A5 JP2012505178 A5 JP 2012505178A5
Authority
JP
Japan
Prior art keywords
ruminant
dopamine receptor
composition
administered
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011530475A
Other languages
English (en)
Japanese (ja)
Other versions
JP5955561B2 (ja
JP2012505178A (ja
Filing date
Publication date
Priority claimed from FR0805544A external-priority patent/FR2936710B1/fr
Application filed filed Critical
Publication of JP2012505178A publication Critical patent/JP2012505178A/ja
Publication of JP2012505178A5 publication Critical patent/JP2012505178A5/ja
Application granted granted Critical
Publication of JP5955561B2 publication Critical patent/JP5955561B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011530475A 2008-10-07 2009-10-07 反芻動物のための獣医用抗プロラクチン組成物 Active JP5955561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0805544A FR2936710B1 (fr) 2008-10-07 2008-10-07 Composition veterinaire antiprolactinique destinee aux ruminants
FR0805544 2008-10-07
PCT/EP2009/063004 WO2010040765A1 (fr) 2008-10-07 2009-10-07 Composition veterinaire antiprolactinique destinee aux ruminants

Publications (3)

Publication Number Publication Date
JP2012505178A JP2012505178A (ja) 2012-03-01
JP2012505178A5 true JP2012505178A5 (https=) 2012-06-07
JP5955561B2 JP5955561B2 (ja) 2016-07-20

Family

ID=40527505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011530475A Active JP5955561B2 (ja) 2008-10-07 2009-10-07 反芻動物のための獣医用抗プロラクチン組成物

Country Status (24)

Country Link
US (2) US9730923B2 (https=)
EP (1) EP2349272B1 (https=)
JP (1) JP5955561B2 (https=)
KR (2) KR101892559B1 (https=)
CN (1) CN102215843B (https=)
AU (1) AU2009301134B2 (https=)
BR (1) BRPI0914064A2 (https=)
CA (1) CA2738875C (https=)
DK (1) DK2349272T3 (https=)
ES (1) ES2719844T3 (https=)
FR (1) FR2936710B1 (https=)
HU (2) HUE043239T2 (https=)
IL (1) IL212125B (https=)
MA (1) MA32763B1 (https=)
MX (1) MX2011003743A (https=)
NO (1) NO2019028I1 (https=)
NZ (1) NZ592288A (https=)
PL (1) PL2349272T3 (https=)
PT (1) PT2349272T (https=)
RU (1) RU2528892C2 (https=)
SI (1) SI2349272T1 (https=)
UA (1) UA103779C2 (https=)
WO (1) WO2010040765A1 (https=)
ZA (1) ZA201103273B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971423B1 (fr) 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
EP2995297A1 (fr) * 2014-09-09 2016-03-16 Ceva Sante Animale Compositions parentérales et leurs utilisations
US20200071408A1 (en) 2016-11-29 2020-03-05 National Center Of Neurology And Psychiatry Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
EP4064854A1 (en) 2019-11-28 2022-10-05 Boehringer Ingelheim Vetmedica GmbH Use of sglt-2 inhibitors in the drying-off of non-human mammals
UY39022A (es) * 2020-01-27 2021-07-30 Ceva Sante Animale Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria
AR122366A1 (es) * 2020-01-27 2022-09-07 Ceva Sante Animale Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839171A (en) * 1984-11-30 1989-06-13 Techmix, Inc. Composition for treating impaired lactation
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
NZ515178A (en) * 2001-11-23 2004-09-24 Agres Ltd Modulating prolactin receptors to affect a physiological response
GB0313892D0 (en) * 2003-06-16 2003-07-23 Hannah Res Inst Control of lactation
GB0314469D0 (en) 2003-06-20 2003-07-23 Phico Therapeutics Ltd Antimicrobial compositions and uses thereof
CN1762495B (zh) * 2004-09-21 2011-04-06 山东绿叶制药有限公司 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺
KR20070059161A (ko) * 2004-09-21 2007-06-11 산동 루예 파마슈티칼 컴파니 리미티드 도파민 수용체 효능제를 함유하는 장시간 작용 서방성 제제및 그 제조방법
EP1952813A1 (en) * 2007-02-01 2008-08-06 Ferring International Center S.A. Medicament for the treatment of endometriosis
ITTO20070479A1 (it) * 2007-07-02 2009-01-03 Ceva Vetem S P A Composizione veterinaria iniettabile ad attivita' anti-prolattinica

Similar Documents

Publication Publication Date Title
JP2012505178A5 (https=)
RU2011118366A (ru) Ветеринарная антипролактиновая композиция для жвачных
JP2009298801A5 (https=)
FI2981269T3 (fi) Aineenvaihduntahäiriöiden hoito hevoseläimillä
Van Wettere et al. Effect of oral polyamine supplementation pre-weaning on piglet growth and intestinal characteristics
RU2014102944A (ru) Композиция вакцины для трансдермального или трансмукозального введения
US20140024670A1 (en) Veterinary anti-prolactin composition for ruminants
JP7154384B2 (ja) 乳牛の乾乳における経口ボーラスの使用
EA200802159A1 (ru) Введение агониста-антагониста пациентам с опиоидной зависимостью
CZ20031433A3 (cs) Nové použití kombinovaných 5-HT1A agonistů a inhibitorů reabsorpce serotoninu
Daels Induction of lactation and adoption of the orphan foal
CN104285881B (zh) 一种肥尾羊断尾的方法
RU2016116810A (ru) Ветеринарный способ индукции рвоты
JP2012513411A5 (https=)
JP6556526B2 (ja) モサプリドクエン酸塩におけるウシの消化器疾患の予防剤または治療剤
RU2283648C2 (ru) Новое применение комбинированных селективных антагонистов допаминового рецептора d2 и агонистов рецептора 5-нт 1a
Satheesha et al. Clinical evaluation of lithium antimony thiomalate against papillomatosis in bovines and canines
Suman et al. Residual Effect of Experimental Advocation of Levofloxacin in Broiler Birds
H Najafzadeh Determination of furazolidone residues in muscles of the cultured common carp following experimental bath and oral administration
AR122365A1 (es) Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria
KR101823378B1 (ko) 경화유지로 코팅된 인도메타신을 포함하는 비육 촉진용 조성물 및 이의 용도
Wickramasinghe et al. L-Glutamine improves weight gain and starter intake in Holstein heifer calves weaned early from a high volume of milk.
Hernandez Characterization of the bovine mammary gland serotonergic system
RU2009111098A (ru) Способ лечения алкогольной, опийной и табачной зависимости "универсальный психофармакологический нейрофизиологический блок"
Marzok et al. Use of romifidine in dromedary camels.